Complete

A new ground-breaking approach to bile duct cancer and liver cancer

Cancer types:

Liver cancer

Project period:

Research institute:

Vlaams Instituut voor Biotechnologie vzw

Award amount:

£213,592

Location:

Belgium

Researcher Professor Georg Halder

Professor Halder and his colleagues want to better understand a novel treatment approach called “regenerative cancer therapy”. They hope that this recently discovered approach could one day be used in different types of liver cancer, including rarer bile duct cancer. 

Hope for the future

Rates of liver cancer, including bile duct cancer, have been soaring since the 1970's, but treatment remains a challenge. Because of this, there is an urgent need for new therapeutic approaches. One such exciting new therapeutic approach was recently discovered in Professor Halder’s lab.

The science

Professor Halder and his team found that stimulating natural liver generation in normal liver cells around liver tumours caused the tumour to shrink dramatically. This remarkable discovery identifies a completely new strategy to fight cancer that they call “Regenerative Cancer Therapy”. 

Most liver cancers occur in livers that are already damaged by the accumulation of fat or alcohol. This is why Professor Halder is now studying the effects of this new therapy on different human cancer cells in diseased livers.  He and his team expect their project to uncover more information about this new bold therapeutic approach, hopefully paving the way for its use in patients in the future. 

Related projects

Active Italy

Liver cancer

Why do some people with liver disease go on to develop liver cancer?

Researchers are exploring how liver cells respond to stress causes by liver disease,  how this links to cancer development and if it can be stopped. 

Researcher: Professor Giannino Del Sal

Uncovering the connection between liver disease and liver cancer

Active Spain

Liver cancer

How does liver cancer grow in children and how can we stop it?

Looking for new cures for hepatoblastoma, the most common type of liver cancer in children, by studying ‘mini tumours’ to discover how it develops. 

Researcher: Dr Pau Sancho-Bru

Growing mini tumours in the lab to understand hepatoblastoma

Active Italy

Liver cancer

How do mutated proteins make liver cancer more likely?

Researchers are hoping to discover new ways to diagnose liver cancer more accurately, which would help patients receive better treatments more quickly.

Researcher: Dr Fulvio Chiacchiera

When prevention fails: Understanding how mutated proteins make liver cancer more likely
Share this page